Cysteamine derivatives for oral treatment of seborrhea
    2.
    发明授权
    Cysteamine derivatives for oral treatment of seborrhea 失效
    半胱胺衍生物用于口腔治疗皮脂溢

    公开(公告)号:US3950542A

    公开(公告)日:1976-04-13

    申请号:US468595

    申请日:1974-05-09

    摘要: A method for treating a scalp characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with, as a non-toxic active compound, cysteine or cysteamine derivatives, the active compound is present in amounts of about 0.75-3 weight percent of the composition which is administered at a rate of about 1-5 mg/kg/day based on the weight of the human being during a period of about 15 days.

    摘要翻译: 一种用于治疗特征在于皮脂过度分泌的头皮的方法,通过减少所述过度分泌来改善其状况,包括口服给予具有头皮的人,其特征在于包含与作为非皮肤的头发混合的可摄取载体的治疗组合物, 有毒活性化合物,半胱氨酸或半胱胺衍生物,活性化合物的存在量为组合物的约0.75-3重量%,其以约1-5mg / kg /天的速率施用,基于人体重量 在约15天的时间内。